{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:52:36Z","timestamp":1792068756811,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Anti-M\u00fcllerian hormone reflects the continuum of the functional ovarian reserve, and as such can predict ovarian response to gonadotropin stimulation and be used to individualize treatment pathways to improve efficacy and safety. However, consistent with other biomarkers and age-based prediction models it has limited ability to predict live birth and should not be used to refuse treatment, but rather to inform counselling and shared decision making. The use of absolute clinical thresholds to stratify patient phenotypes, assess discordance and individualize treatment protocols in non-validated algorithms combined with the lack of standardization of assays may result in inappropriate classification and sub-optimal clinical decision making. We propose that holistic baseline phenotyping, incorporating antral follicle count and other patient characteristics is critical. Treatment decisions driven by validated algorithms that use ovarian reserve biomarkers as continuous measures, reducing the risk of misclassification, are likely to improve overall outcomes for our patients.<\/jats:p>","DOI":"10.3389\/fendo.2020.606744","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T23:49:04Z","timestamp":1607557744000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical Application of AMH Measurement in Assisted Reproduction"],"prefix":"10.3389","volume":"11","author":[{"given":"Hang Wun Raymond","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590701532815","article-title":"Anti-M\u00fcllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history","volume":"23","author":"Nardo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e61095","DOI":"10.1371\/journal.pone.0061095","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.fertnstert.2015.01.004","article-title":"Prospective study into the value of the automated Elecsys antim\u00fcllerian hormone assay for the assessment of the ovarian growing follicle pool","volume":"103","author":"Anderson","year":"2015","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antim\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.07.1674","article-title":"Anti-M\u00fcllerian hormone and inhibin B variability during normal menstrual cycles","volume":"94","author":"Sowers","year":"2010","journal-title":"Fertil Steril"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1141-5","article-title":"Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles","volume":"35","author":"Gracia","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"IPD-EXPORT Study Group. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der318","article-title":"Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","first-page":"CD005356","DOI":"10.1002\/14651858.CD005356.pub2","article-title":"Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists\/antagonists) for intrauterine insemination (IUI) in women with subfertility","author":"Cantineau","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn034","article-title":"The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis","volume":"14","author":"van Rumste","year":"2008","journal-title":"Hum Reprod Update"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1023\/a:1022518103368","article-title":"The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hypertimulation\/intrauterine insemination program","volume":"15","author":"Chang","year":"1998","journal-title":"J Assist Reprod Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.06.028","article-title":"Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility","volume":"90","author":"Erdem","year":"2008","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-005-6785-2","article-title":"The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination","volume":"22","author":"Ng","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"Li","year":"2010","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2014.935718","article-title":"A higher anti-M\u00fcllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination","volume":"35","author":"Wang","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation","volume":"31","author":"Bakas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.08.021","article-title":"Anti-M\u00fcllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination","volume":"133","author":"Moro","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1110138","article-title":"Limited ability of circulating anti-M\u00fcllerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays","volume":"32","author":"Vaiarelli","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4906-2","article-title":"Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman\u2019s age and markers of ovarian reserve","volume":"298","author":"Di Paola","year":"2018","journal-title":"Gynecol Obstet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-M\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.17296","article-title":"Live-birth rate associated with repeat in vitro fertilization treatment cycles","volume":"314","author":"Smith","year":"2015","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"B36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/GCO.0b013e3283384911","article-title":"The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome","volume":"22","author":"Broer","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der446","article-title":"Anti-Mullerian hormone: clairvoyance or crystal clear","volume":"27","author":"Nelson","year":"2012","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","first-page":"CD012693","DOI":"10.1002\/14651858.CD012693.pub2","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew248","article-title":"Comparative evaluation of three new commercial immunoassays for anti-M\u00fcllerian hormone measurement","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex219","article-title":"Non-equivalence of anti-M\u00fcllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Hum Reprod"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"B46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1196\/annals.1434.012","article-title":"Clinical efficiency of oocyte and embryo cryopreservation","volume":"1127","author":"Borini","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.01.024","article-title":"Association of serum anti-M\u00fcllerian hormone and other factors with cumulative live birth rate following IVF","volume":"40","author":"Hu","year":"2020","journal-title":"Reprod BioMed Online"},{"key":"B48","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1038\/s41598-020-68896-1","article-title":"Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF\/ICSI cycles: a single-center retrospective study","volume":"10","author":"Abdullah","year":"2020","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez051","article-title":"OPTIMIST study group. Cumulative live birth rates in low-prognosis women","volume":"34","author":"Leijdekkers","year":"2019","journal-title":"Hum Reprod"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-M\u00fcllerian hormone versus antral follicle count for defining the starting dose of FSH","volume":"27","author":"Lan","year":"2013","journal-title":"Reprod BioMed Online"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20402","article-title":"Comparison of antral follicle count and serum anti M\u00fcllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial","volume":"55","author":"Li","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e108493","DOI":"10.1371\/journal.pone.0108493","article-title":"Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1477-7827-10-94","article-title":"A new ovarian response prediction index (ORPI): implications for individualized controlled ovarian stimulation","volume":"10","author":"Oliveira","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20160021","article-title":"The ovarian response prediction index (ORPI) as a clinical internal quality control to prevent ovarian hyperstimualtion syndrome","volume":"20","author":"Oliveira","year":"2016","journal-title":"JBRA Assist Reprod"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/14647273.2020.1805517","article-title":"Performance of ovarian response prediction index (ORPI) in predicting ovarian response and livebirth in the in-vitro fertilisation cycle using a standard stimulation with corifollitropin alpha in a GnRH antagonist protocol","author":"Ng","year":"2020","journal-title":"Hum Fertil"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13956","article-title":"Anti-M\u00fcllerian hormone variability and its implications for the number of oocytes retrieved following individualized dosing with follitropin delta","volume":"90","author":"Nelson","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rbmo.2020.03.023","article-title":"The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa","volume":"41","author":"Neves","year":"2020","journal-title":"Reprod BioMed Online"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2019.03.002","article-title":"Comparing early embryo morphokinetics with time-lapse microscopy in patients with low and normal ovarian response to ovarian stimulation","volume":"19","author":"Alexopoulou","year":"2019","journal-title":"Reprod Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.20.04546-3","article-title":"Anti-M\u00fcllerian hormone and embryo quality as determined by time-lapse imaging","volume":"72","author":"Korkidakis","year":"2020","journal-title":"Minerva Ginecol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12958-019-0492-9","article-title":"Anti-M\u00fcllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development","volume":"17","author":"O\u2019Brien","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez186","article-title":"Oocyte matched follicular fluid anti-M\u00fcllerian hormone is an excellent predictor of live birth after fresh single embryo transfer","volume":"34","author":"Ciepiela","year":"2019","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.606744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T23:49:06Z","timestamp":1607557746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.606744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":61,"alternative-id":["10.3389\/fendo.2020.606744"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.606744","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"article-number":"606744"}}